[go: up one dir, main page]

Shibata et al., 1996 - Google Patents

Helicobacter pylori infection in patients with gastric carcinoma in biopsy and surgical resection specimens

Shibata et al., 1996

View PDF
Document ID
921207841740405390
Author
Shibata T
Imoto I
Ohuchi Y
Taguchi Y
Takaji S
Ikemura N
Nakao K
Shima T
Publication year
Publication venue
Cancer: Interdisciplinary International Journal of the American Cancer Society

External Links

Snippet

BACKGROUND The discrepancy between the high seropositivity for Helicobacter pylori (H. pylori) and the low diagnostic yield of H. pylori organism in gastric biopsies of patients with gastric carcinoma has yet to be clarified. The present study attempted to clarify this …
Continue reading at acsjournals.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature

Similar Documents

Publication Publication Date Title
Haruma et al. Helicobacter pylori infection is a major risk factor for gastric carcinoma in young patients
Miki et al. Using serum pepsinogens wisely in a clinical practice
Kokkola et al. Helicobacter pylori infection in young patients with gastric carcinoma
Meining et al. Gastric carcinoma risk index in patients infected with Helicobacter pylori
Anastasios et al. Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings
Ricuarte et al. Atrophic gastritis in young children and adolescents
Kuipers et al. Helicobacter pylori serology in patients with gastric carcinoma
Labenz et al. Validity of a novel biopsy urease test (HUT) and a simplified 13C-urea breath test for diagnosis of Helicobacter pylori infection and estimation of the severity of gastritis
Endo et al. Detection of Helicobacter pylori infection in early stage gastric cancer. A comparison between intestinal‐and diffuse‐type gastric adenocarcinomas
Shibata et al. Helicobacter pylori infection in patients with gastric carcinoma in biopsy and surgical resection specimens
Shrestha et al. Prevalence study of H. pylori infection in dyspeptic patients coming to Nepal Medical College Teaching Hospital, Jorpati, Kathmandu.
Miehlke et al. Histological diagnosis of Helicobacter pylori gastritis is predictive of a high risk of gastric carcinoma
Martin-de-Argila et al. Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori
Rudi et al. Lack of association of Helicobacter pylori seroprevalence and gastric cancer in a population with low gastric cancer incidence
Shimoyama et al. Evaluation of the applicability of the gastric carcinoma risk index for intestinal type cancer in Japanese patients infected with Helicobacter pylori
Yuan et al. Helicobacter pylori infection and risk of gastric cancer in Shanghai, China: updated results based upon a locally developed and validated assay and further follow-up of the cohort
Suriani et al. CagA and VacA Helicobacter pylori antibodies in gastric cancer
Wabinga Comparison of immunohistochemical and modified Giemsa stains for demonstration of Helicobacter pylori infection in an African population
Tabata et al. Helicobacter pylori and Mucosal Atrophy in Patients with Gastric Cancer (A Special Study Regarding the Methods for Detecting Helicobacter pylori)
Nakamura Laboratory tests for the evaluation of Helicobacter pylori infections
Kitahara et al. Severe atrophic gastritis with Helicobacter pylori infection and gastric cancer
You et al. Serum pepsinogens in relation to precancerous gastric lesions in a population at high risk for gastric cancer.
Sharma et al. Histopathological Spectrum of various gastroduodenal lesions in North India and prevalence of Helicobacter pylori infection in these lesions: a prospective study
Young et al. The genetics, epidemiology, and early detection of gastrointestinal cancers
Tsukui et al. Aging increases, and duodenal ulcer reduces the risk for intestinal metaplasia of the gastric corpus in Japanese patients with dyspepsia